C&R Research Inc. (KOSDAQ:359090)
South Korea · Delayed Price · Currency is KRW 898.00
+17.00 (1.93%)
At close: Jan 29, 2026
C&R Research Market Cap
C&R Research has a market cap or net worth of 51.61 billion as of January 30, 2026. Its market cap has decreased by -24.06% in one year.
Market Cap
51.61B
Enterprise Value
46.30B
Revenue
63.97B
Ranking
n/a
PE Ratio
18.27
Stock Price
898.00
Market Cap Chart
Since December 9, 2021, C&R Research's market cap has increased from 3.81B to 51.61B, an increase of 1,254.55%. That is a compound annual growth rate of 87.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 50.46B | -2.44% |
| Dec 30, 2025 | 51.72B | -21.53% |
| Dec 30, 2024 | 65.91B | 0.98% |
| Dec 28, 2023 | 65.27B | 5.47% |
| Dec 29, 2022 | 61.89B | -42.89% |
| Dec 30, 2021 | 108.38B | 2,744.60% |
| Dec 9, 2021 | 3.81B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hyundai ADM Bio | 171.96B |
| DreamCIS | 148.98B |
| HLB bioStep | 140.56B |
| LabGenomics | 130.22B |
| P&K Skin Research Center | 70.04B |
| WOOJUNG BIO | 38.29B |
| DT&CRO CO. | 31.90B |
| SLS BIO | 26.89B |